NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.81
+0.87 (2.56%)
At close: Jan 22, 2026, 4:00 PM EST
34.81
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:00 PM EST
NAMS Stock Forecast
Stock Price Forecast
The 9 analysts that cover NAMS stock have a consensus rating of "Strong Buy" and an average price target of $46.56, which forecasts a 33.75% increase in the stock price over the next year. The lowest target is $37 and the highest is $52.
Price Target: $46.56 (+33.75%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 4 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +35.02% | Jan 21, 2026 |
| Stifel | Stifel | Strong Buy Maintains $44 → $50 | Strong Buy | Maintains | $44 → $50 | +43.64% | Dec 16, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +6.29% | Dec 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +26.40% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $40 → $46 | Strong Buy | Maintains | $40 → $46 | +32.15% | Nov 5, 2025 |
Financial Forecast
Revenue This Year
28.15M
from 45.56M
Decreased by -38.22%
Revenue Next Year
31.09M
from 28.15M
Increased by 10.46%
EPS This Year
-1.49
from -2.56
EPS Next Year
-1.75
from -1.49
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 55.1M | 81.9M | ||||
| Avg | 28.1M | 31.1M | ||||
| Low | 22.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21.0% | 191.0% | ||||
| Avg | -38.2% | 10.5% | ||||
| Low | -51.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.98 | -1.30 | ||||
| Avg | -1.49 | -1.75 | ||||
| Low | -1.70 | -2.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.